Barbiturates and benzodiazepines are GABA receptor–potentiating CNS depressants used in psychiatric and neurologic pharmacology, distinguished by chemical class (barbituric acid derivatives vs. the benzodiazepine ring with a characteristic suffix), therapeutic index, and overdose/withdrawal pharmacodynamics. Barbiturates have a narrow therapeutic index and no receptor antagonist, producing dose-dependent respiratory depression on overdose, whereas benzodiazepines have a wider safety margin, spare respiratory drive, and are reversible with a specific competitive receptor antagonist. Both drug classes share a common withdrawal syndrome mechanism rooted in abrupt loss of GABAergic inhibition, placing them within the broader pharmacologic category of sedative-hypnotic CNS depressants alongside alcohol.
Barbiturates and benzodiazepines are GABA receptor–potentiating CNS depressants used in psychiatric and neurologic pharmacology, distinguished by chemical class (barbituric acid derivatives vs. the b…